Deschenes Roger P. 4
4 · IMPLANT SCIENCES CORP · Filed Sep 11, 2012
Insider Transaction Report
Form 4
IMPLANT SCIENCES CORPOTCBB:IMSC
Deschenes Roger P.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2012-09-07+1,058,498→ 1,058,498 totalExercise: $1.40Exp: 2022-09-06→ Common Stock (1,058,498 underlying)
Footnotes (1)
- [F1]One-half of the shares subject to this option are immediately exercisable and the other one-half will become exercisable on September 7, 2013.